H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX) Jun 4, 2026 06:40AM
argenx SE (ARGX) PT Raised to $1,255 at Stifel May 28, 2026 04:07PM
RBC Capital Reiterates Outperform Rating on argenx SE (ARGX), 'We Would Remain Buyers Ahead of Busy Calendar" May 8, 2026 06:33AM
argenx (ARGX) Tops Q1 EPS by 7c May 7, 2026 06:12AM
argenx names Karen Massey as CEO, Van Hauwermeiren becomes chairman May 6, 2026 04:02PM
View Older Stories

Apr 19, 2026 10:00AM These are the best biotech stocks to own in 2026: BofA
Apr 16, 2026 01:00AM Goldman sees a buying opportunity in this EU biopharma stock
Apr 14, 2026 09:08AM TD Cowen Reiterates Buy Rating on argenx SE (ARGX)
Apr 1, 2026 06:00AM Goldman just updated its European Conviction List. Here is what's changed
Mar 16, 2026 05:27PM argenx SE (ARGX) PT Raised to $1,013 at Jefferies
Mar 13, 2026 09:32AM TD Cowen: 'argenx SE (ARGX) Unlocking Major Growth With Vision 2030 In Sight'
Mar 11, 2026 03:55AM Deutsche Bank Upgrades argenx SE (ARGX:BB) (ARGX) to Buy
Mar 10, 2026 04:03PM Deutsche Bank Upgrades argenx SE (ARGX) to Buy
Feb 27, 2026 02:20PM argenx SE (ARGX) PT Raised to $1,060 at Oppenheimer
Feb 27, 2026 04:25AM argenx SE (ARGX) PT Raised to $944 at Citizens After Positive Results in Ocular MG
Feb 26, 2026 12:20PM argenx SE (ARGX) PT Raised to $1,013 at BofA Securities
Feb 26, 2026 11:52AM argenx SE (ARGX) PT Lowered to $1,227 at Stifel
Feb 26, 2026 02:49AM argenx (ARGX) Tops Q4 EPS by 207c
Jan 12, 2026 01:21PM William Blair on argenx SE (ARGX): 'we believe there are opportunities for further share upside'
Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC
Jan 6, 2026 06:43AM H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX)
Jan 5, 2026 10:15AM TD Cowen: 'we are confident that this leadership transition is designed to support argenx’s next phase of growth'
Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
Dec 18, 2025 06:24AM BofA: 'Top SMid Biotech Picks Argenx, KalVista, Ocular, and Vertex'
Dec 18, 2025 06:17AM argenx SE (ARGX) PT Raised to $1,006 at BofA Securities, 'remains one of our top picks for 2026'
Dec 18, 2025 02:49AM Baird Downgrades argenx SE (ARGX) to Neutral
Dec 17, 2025 07:38AM 'argenx SE (ARGX) Is One Of Our Top Picks For 2026'; PT Raised at RBC Capital
Dec 15, 2025 01:32PM Jefferies Reiterates Buy Rating on argenx SE (ARGX)
Dec 15, 2025 10:25AM Guggenheim on argenx SE (ARGX): 'Long-term Growth Thesis Intact'
Dec 15, 2025 10:24AM BofA Securities on argenx SE (ARGX): '2026 remains a catalyst-rich year'
Dec 15, 2025 06:56AM argenx discontinues thyroid eye disease studies after futility analysis
Dec 11, 2025 07:46AM argenx SE (ARGX) PT Raised to $1,248 at Stifel: Vyvgart Dominates MG Market
Dec 9, 2025 06:23AM argenx SE (ARGX) PT Raised to $910 at UBS
Nov 24, 2025 02:30PM argenx (ARGX) 500 contracts of May 1100 calls trade
Nov 24, 2025 05:32AM Wolfe Research Downgrades argenx SE (ARGX) to Peerperform
Nov 19, 2025 08:29AM argenx SE (ARGX) PT Raised to $1,040 at Oppenheimer
Nov 17, 2025 05:23AM argenx SE (ARGX) PT Raised to $1,124 at Citi
Nov 4, 2025 08:24AM 'argenx SE (ARGX) Remains a Top Pick'; PT Raised to $930 at Piper Sandler
Oct 31, 2025 09:19AM 'argenx SE (ARGX) Remains a Top Pick'; PT Raised to $1,146 at TD Cowen
Oct 30, 2025 03:19AM argenx (ARGX) Tops Q3 EPS by 74c; offers guidance
Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'
Oct 15, 2025 08:14AM TD Cowen Reiterates Buy Rating on argenx SE (ARGX)
Sep 29, 2025 09:00AM RBC Capital on argenx SE (ARGX): 'We Would Remain Buyers'
Sep 18, 2025 02:47PM argenx SE (ARGX) PT Raised to $882 at Stifel
Sep 18, 2025 05:08AM Oppenheimer Reiterates Outperform Rating on argenx SE (ARGX)
Sep 17, 2025 07:43AM Truist Securities Reiterates Buy Rating on argenx SE (ARGX)
Sep 15, 2025 07:36AM Truist Securities Assumes argenx SE (ARGX) at Buy
Sep 12, 2025 03:59AM Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
Sep 8, 2025 09:46AM BofA Securities on argenx SE (ARGX): 'We see multiple shots on goal to expand the commercial opportunity with multiple phase 3 readouts for Vyvgart'
Aug 26, 2025 08:02AM argenx SE (ARGX) PT Raised at Piper Sandler Following Successful Seronegative gMG Readout
Aug 26, 2025 07:21AM JPMorgan Reiterates Overweight Rating on argenx SE (ARGX:BB) (ARGX)
Aug 26, 2025 05:26AM argenx SE (ARGX) PT Raised to $808 at Jefferies
Aug 25, 2025 04:30PM Oppenheimer Reiterates Outperform Rating on argenx SE (ARGX)
Aug 25, 2025 12:40PM RBC on argenx SE (ARGX): 'Vyvgart Hits in snMG, TAM Likely to Be Expanded by an Additional 11k Patients'
View Older Stories